Drug Development

Apr 24, 2017
By Pharmaceutical Technology Editors
Sandoz has received positive opinions from EMA’s CHMP for its biosimilars rituximab and etanercept for all indications of their respective reference medicines.
Apr 18, 2017
By Pharmaceutical Technology Editors
The funding allows the company to broaden its range of services and finance its move to new laboratory facilities in the Illkirch-Graffenstaden innovation park in northeast France.
Apr 17, 2017
By Pharmaceutical Technology Editors
The two companies will develop translational biomarkers for fibrotic diseases, including non-alcoholic steatohepatitis (NASH).
Apr 07, 2017
By Pharmaceutical Technology Editors
A drop in US drug approvals was noted but this trend was not yet seen in Europe.
Apr 06, 2017
FDA is in the center of the debate over developing and pricing new cancer therapies.
Apr 02, 2017
Pharmaceutical Technology
Interpretation of calorimetric data is tricky. The author suggests 10 questions that should be asked of any calorimetric method, along with the rationales behind them.
Apr 02, 2017
Pharmaceutical Technology
Anil Kane, executive director, Global Head of Formulation Sciences, Pharmaceutical Development Services at Patheon discusses key parameters in the development and manufacturing of oral solid-dosage forms.
Apr 02, 2017
Pharmaceutical Technology
David Fulper, PhD, director of technology support at Catalent, shares insights on the challenges and opportunities for cannabis-based therapeutics.
Apr 02, 2017
Pharmaceutical Technology
Design of experiment plays a crucial role in the optimization process of formulation development.
Mar 29, 2017
By Pharmaceutical Technology Editors
Under the agreement, Laurus Synthesis will provide chemistry development services and manufacturing in support of an upcoming clinical trial evaluating EPX-100 in adolescents suffering from Dravet syndrome.
native1_300x100
lorem ipsum